Kenichi Akamatsu is the founder of Megakaryon Corporation. Megakaryon Corporation has raised $650M in total funding. Based in Kyoto, Japan.
Kenichi Akamatsu is the CEO and President of Megakaryon Corporation, a Kyoto-based biotechnology venture founded in 2011 that develops platelet products using human iPS cells. He has led the company through multiple funding rounds, including Series C and Series D, securing over 10 billion yen in total funding. In December 2023, Megakaryon became a consolidated subsidiary of Sysmex Corporation under his continued leadership.
Full founder directory · Investor directory · Company funding database · Fundraising library